Close

Form 4 USANA HEALTH SCIENCES For: Oct 30 Filed by: Jones Paul A.

November 3, 2014 1:55 PM EST
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: December 31, 2014
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person *
Jones Paul A.

(Last) (First) (Middle)
3838 WEST PARKWAY BLVD.

(Street)
SALT LAKE CITY UT 84120

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
USANA HEALTH SCIENCES INC [ USNA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
CFO
3. Date of Earliest Transaction (Month/Day/Year)
10/30/2014
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/30/2014   M   6,372 (1) A $ 39.4 6,372 D  
Common Stock 10/30/2014   S   6,372 D $ 105.0969 (2) 0 D  
Common Stock 10/30/2014   M   4,451 (1) A $ 38.23 4,451 D  
Common Stock 10/30/2014   S   4,451 D $ 105.0969 (2) 0 D  
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock-Settled Stock Appreciation Rights $ 39.4 10/30/2014   M     10,200 07/26/2011 01/26/2016 Common Stock 10,200 $ 0 10,200 D  
Stock Settled Stock Appreciation Rights $ 38.23 10/30/2014   M     7,000 12/17/2013 06/17/2018 Common Stock 7,000 $ 0 28,000 D  
Explanation of Responses:
1. The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table II.
2. Weighted average price. Price range in multiple transactions was $105.00 to $105.60, inclusive.
James Bramble, as attorney in fact 11/03/2014
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
LIMITED POWER OF ATTORNEY FOR 
SECTION 16 REPORTING OBLIGATIONS

           Know all by these presents, that the undersigned 
hereby makes, constitutes and appoints each of Joshua P. Foukas 
and James H. Bramble, each acting individually, as the 
undersigned's true and lawful attorney-in-fact, with full power 
and authority as hereinafter described on behalf of and in the 
name, place and stead of the undersigned to:

           (1)        Prepare, execute, acknowledge, deliver and 
file Forms 3, 4, 5 and 144 (including any amendments thereto) 
with respect to the securities of USANA Health Sciences, Inc., a 
Utah corporation (the "Company"), with the United States 
Securities and Exchange Commission, any national securities 
exchanges and the Company, as considered necessary or advisable 
under Section 16(a) of the Securities Exchange Act of 1934 and 
the rules and regulations promulgated thereunder, as amended from 
time to time (the "Exchange Act");

           (2)        Seek or obtain, as the undersigned's 
representative and on the undersigned's behalf, information on 
transactions in the Company's securities from any third party, 
including brokers, employee benefit plan administrators and 
trustees, and the undersigned hereby  authorizes any such person 
to release any such information to the undersigned and approves 
and ratifies any such release of information; and
           
           (3)        Perform any and all other acts which in the 
discretion of such attorney-in-fact are necessary or desirable 
for and on behalf of the undersigned in connection with the 
foregoing.
           
           The undersigned acknowledges that:
           
           (1)        This Power of Attorney authorizes, but does 
not require, each such 
attorney-in-fact to act in his or her discretion on information 
provided to such attorney-in-fact without independent 
verification of such information;
           
           (2)        Any documents prepared and/or executed by 
either such attorney-in-fact on behalf of the undersigned 
pursuant to this Power of Attorney will be in such form and will 
contain such information and disclosure as such attorney-in-fact, 
in his or her discretion, deems necessary or desirable;
           
           (3)        Neither the Company nor either of such 
attorneys-in-fact assumes (i) any liability for the undersigned's 
responsibility to comply with the requirement of the Exchange Act, 
(ii) any liability of the undersigned for any failure to comply 
with such requirements, or (iii) any
obligation or liability of the undersigned for profit 
disgorgement under Section 16(b) of the Exchange Act; and
           
           (4)        This Power of Attorney does not relieve the 
undersigned from responsibility for compliance with the 
undersigned's obligations under the Exchange Act, including 
without limitation the reporting requirements under Section 16 of 
the Exchange Act.
           
           The undersigned hereby gives and grants each of the 
foregoing attorneys-in-fact full power and authority to do and 
perform all and every act and thing whatsoever requisite, 
necessary or appropriate to be done in and about the foregoing 
matters as fully to all intents and purposes as the undersigned 
might or could do if present, hereby ratifying all that each such  
attorney-in-fact of, for and on behalf of the undersigned, shall 
lawfully do or cause to be done by virtue of this Limited Power 
of Attorney.

           This Power of Attorney shall remain in full force and 
effect until revoked by the undersigned in a signed writing 
delivered to each such attorney-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of 
Attorney to be executed as of this 2 day of October, 2014.

/s/ Paul A. Jones
Paul A. Jones





Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings